Evidence map›Paper›PMID 37202490›Full record

ArticleNature immunology2023

PI16

Angelina De Martin, Yves Stanossek, Mechthild Lütge, Nadine Cadosch, Lucas Onder, Hung-Wei Cheng, Joshua D Brandstadter, Ivan Maillard, Sandro J Stoeckli, Natalia B Pikor and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Mechanical Strain-Programmed SDC1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Article
  10. Fibroblast diversity within human gut-associated lymphoid tissues.The Journal of experimental medicine · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Angelina De Martin *Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Yves Stanossek *Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Mechthild LütgeInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID http://orcid.org/0000-0001-9011-5319
Nadine CadoschInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Lucas OnderInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Hung-Wei ChengInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Joshua D BrandstadterDivision of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0652-5791
Ivan MaillardDivision of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1312-6748
Sandro J StoeckliDepartment of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Natalia B PikorInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID http://orcid.org/0000-0002-6564-4232
Burkhard LudewigInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland. burkhard.ludewig@kssg.ch.ORCID http://orcid.org/0000-0002-7685-573X
Kantonsspital St. Gallen · CHUniversity of Pennsylvania · US

Funding

HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
Notch Signaling in AlloimmunityR01AI091627 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PEAR, WARREN S · 2011 to 2025
$6.0M
NHLBI NIH HHS T32 HL007439NIAID NIH HHS R01 AI091627
6 · The paper itself

Abstract

Fibroblastic reticular cells (FRCs) direct the interaction and activation of immune cells in discrete microenvironments of lymphoid organs. Despite their important role in steering innate and adaptive immunity, the age- and inflammation-associated changes in the molecular identity and functional properties of human FRCs have remained largely unknown. Here, we show that human tonsillar FRCs undergo dynamic reprogramming during life and respond vigorously to inflammatory perturbation in comparison to other stromal cell types. The peptidase inhibitor 16 (PI16)-expressing reticular cell (PI16

Indexed as

Palatine TonsilT-LymphocytesCarrier ProteinsFibroblastsGlycoproteinsHumansInflammationLymphocytesCarrier ProteinsGlycoproteinsPI16 protein, human

Identifiers

PMID37202490
PMCPMC10307632
OpenAlexW4377019592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.